Speaker

Cecilia Leung

VP of Research, Vivatides Therapeutics

Cecilia Leung, VP of Research at Vivatides Therapeutics, is speaking at 2nd Oligonucleotide-Based Therapeutics Summit (Boston, United States of America, 8–10 Dec 2026) in the session “Screening Beyond GalNAc and TFR & Identifying Which Novel Targeting Ligands Are Actually Worth Pursuing”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

2nd Oligonucleotide-Based Therapeutics Summit
8–10 Dec 2026Boston, United States of America
- SpeakerScreening Beyond GalNAc and TFR & Identifying Which Novel Targeting Ligands Are Actually Worth Pursuing

More speakers at 2nd Oligonucleotide-Based Therapeutics Summit

Julia Alterman
Assistant professor, University of Massachusetts Medical School
Sayantan Chatterjee
Oligonucleotide Chemistry Scientist, Korro Bio
Seymour de Picciotto
CEO, Cellado
Shuhan Huang
Scientist, WYSS
Stephanie Maiocco
VP of Biotherapeutics, Evercrisp
Thomas Ormsby
Associate Professor, University of Massachusetts Medical School

See all 8 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Cecilia Leung, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].